MedPath

Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage

Not Applicable
Completed
Conditions
Brain Damage
Cerebral Palsy
Traumatic Brain Damage
Interventions
Behavioral: Modified Constraint-induced Movement Therapy
Registration Number
NCT01076257
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

This research centers on the comparison of the immediate efficacy (right after therapy) and the maintained efficacy (3 months and 6 months) between "Modified Constraint-Induced Movement Therapy" (mCIMT) group and control group at different age.

Detailed Description

"Modified Constraint-Induced Movement Therapy" is one of the most recent treatments for children with Brain damage.

This well-designed and follow-up RCT study compared home-based CIT with a control intervention (traditional rehabilitation, TR) by combining kinematic analysis and clinical evaluation, which is possible to examine whether functional improvement is accompanied by a change in motor control. We hypothesized that home-based CIT would induce better motor control strategies (shorter RT, MT, lesser MUs, MGA, and PMGA, and larger peak velocity (PV)) for greater functional gains than TR. Furthermore, the beneficial effects would be maintained at 3 and 6 months of follow-up. Findings of this study allow clinicians to understand the underlying motor control changes for functional improvement after home-based CIT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
48
Inclusion Criteria
  1. Development learned-nonuse
  2. Age range 4y/o-15y/o
  3. Wrist ext 10˚, MP j't ext 10˚ in affected U/E
  4. Can fallow up the simple instruction
  5. Modified Ashworth Scale ≦2
  6. Pediatric Motor Activity Log ≦2.5 (average)
Exclusion Criteria
  1. Related muscle skeleton surgery
  2. Selective dorsal rhizotomy
  3. Botulinum toxin in 6 months
  4. Visual perception impaired
  5. Hearing perception impaired
  6. Balance ability impaired (in constrained)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Constraint-induced Movement TherapyModified Constraint-induced Movement Therapy-
Transditional rehabilitationModified Constraint-induced Movement Therapy-
Primary Outcome Measures
NameTimeMethod
Bruininks-Oseretsky Test of Motor Proficiency (BOTMP)4 weeks (post-treatment), 12 week, 24 week

All children underwent a series of upper limb assessments, including kinematic analysis and functional measures (primary and secondary outcomes), before the start of the intervention (pretreatment). An occupational therapist blinded to group assignment was trained to administer these measures. All participants underwent these assessments at 4 weeks immediately after intervention (post-treatment), and at 12-week follow-up and 24-week follow-up.

Peabody Development Motor Scales, subtest fine motor (PDMS-Ⅱ)4 weeks (post-treatment), 12 week, 24 week
Kinematic analysis4 weeks (post-treatment), 12 week, 24 week
Secondary Outcome Measures
NameTimeMethod
Pediatric Motor Activity Log ( PMAL )4 weeks (post-treatment), 12 week, 24 week

All children underwent a series of upper limb assessments, including kinematic analysis and functional measures (primary and secondary outcomes), before the start of the intervention (pretreatment). An occupational therapist blinded to group assignment was trained to administer these measures. All participants underwent these assessments at 4 weeks immediately after intervention (post-treatment), and at 12-week follow-up and 24-week follow-up.

Pediatric Functional Independence Measure ( WeeFIM )4 weeks (post-treatment), 12 week, 24 week
Cerebral palsy quality of life (CPQoL)4 weeks (post-treatment), 12 week, 24 week

Trial Locations

Locations (1)

Chang Gung Memorial Hospital

🇨🇳

Taoyuan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath